Drug application
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE (AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE)
Drugs@FDA ANDA 208111 · PADAGIS ISRAEL
Key facts
| Drug name | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE |
|---|---|
| Active ingredients | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE |
| Application type | ANDA |
| Application number | 208111 |
| Company | PADAGIS ISRAEL |
| Dosage forms | SPRAY, METERED, NASAL |
| Strength | 0.137MG/SPRAY;0.05MG/SPRAY |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Feb 18, 2021 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.